(210) | Number of the EPO application | 17727373 |
(220) | Filing date of the EPO application | 2017.04.18 |
(80) | EPO patent specification publication (B) | EPB nr. 16/2024, 2024.04.17 |
(110) | EPO patent number | 3445388 |
(11) | Number of the document | MD 3445388 T2 |
(21) | Number of the application | e 2019 0261 |
(71) | Name(s) of applicant(s), code of the country | VERTEX PHARMACEUTICALS INCORPORATED, US; |
(72) | Name(s) of inventor(s), code of the country | COWAN Chad Albert, US; LUNDBERG Ante Sven, US; CHAKRABORTY Tirtha, US; LIN Michelle I-ching, US; MISHRA Bibhu Prasad, US; PAIK Elizabeth Jae-eun, US; KERNYTSKY Andrew, US; BORLAND Todd Douglass, US; |
(73) | Name(s) of owner(s), code of the country | VERTEX PHARMACEUTICALS INCORPORATED, US; |
(54) | Title of the invention | Materials and methods for treatment of hemoglobinopathies |
(13) | Kind-of-document code | T2 |
(51) | International Patent Classification | A61K 38/46 (2006.01.01); C12N 9/22 (2006.01.01); C12N 15/10 (2006.01.01); C12N 15/113 (2010.01.01) |
(19) | Country | US |
(41) | Date of publication of the application | 2019.03.31 |
(49) | Date of publication of the translation of the validated European patent specification | 2024.07.31 |
(30) | Priority | 201662324024 P, 2016.04.18, US; 201662382522 P, 2016.09.01, US; 201662429428 P, 2016.12.02, US |
(74) | Patent attorney | (Procedură) SOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chişinău, Republica Moldova |
(86) | International application | PCT/IB2017/000577, 2017.04.18 |
(87) | International publication | WO 2017/182881, 2017.10.26 |